BetterLife Pharma (BETRF) Net Shares Issued and Repurchased (2012 - 2019)
BetterLife Pharma (BETRF) posted Net Shares Issued and Repurchased of $6.2 million for Q1 2019, up 290.88% on a QoQ basis from $1.6 million in Q1 2018, and up 290.88% year-over-year from $1.6 million in Q1 2018.
Analysis
BetterLife Pharma (BETRF) Net Shares Issued and Repurchased (2012 - 2019) Analysis & Trends
BetterLife Pharma has reported Net Shares Issued and Repurchased for 4 years, with the latest figure at $6.2 million in Q1 2019.
- On a quarterly basis, Net Shares Issued and Repurchased rose 290.88% year-over-year to $6.2 million in Q1 2019; TTM through Jan 2019 was $6.2 million, a 290.88% increase from a year earlier, with the FY2019 full-year figure at $6.3 million, up 215.56% from the prior year.
- Net Shares Issued and Repurchased was $6.2 million for Q1 2019 at BetterLife Pharma, up from $1.6 million in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $6.2 million in Q1 2019, with the low at -$80000.0 in Q1 2016.
- Average Net Shares Issued and Repurchased over 3 years is $2.6 million, with a median of $1.6 million recorded in 2018.
- The largest YoY upside for Net Shares Issued and Repurchased was 290.88% in 2019 against a maximum downside of 290.88% in 2019.
- Over 3 years, Net Shares Issued and Repurchased stood at -$80000.0 in 2016, then jumped by 2075.29% to $1.6 million in 2018, then jumped by 290.88% to $6.2 million in 2019.
- The last three Net Shares Issued and Repurchased figures came in at $6.2 million (Q1 2019), $1.6 million (Q1 2018), and -$80000.0 (Q1 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.01 Bn | 193.02 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.98 Bn | 176.80 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.45 Bn | 123.60 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.02 Bn | 74.03 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.35 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.69 Bn | 48.55 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.11 Bn | 29.80 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.93 Bn | 30.64 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.21 Bn | 29.21 Bn | 1.16 Mn | - |
| 10 | BetterLife Pharma | 31.61 Mn | 31.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2019 | 6.18 Mn |
| Jan 31, 2018 | 1.58 Mn |
| Jan 31, 2016 | -80,000.00 |
| Jan 31, 2012 | 43,736.00 |